We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$22.1B
1-Year Est. Return
45.54%
This Fund
S&P 500
This Quarter
Est. Return
-3.31%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$18.5B
AUM Growth
+$95.7M
(+0.52%)
Cap. Flow
+$1.16B
Cap. Flow
% of AUM
6.27%
Top 10 Holdings %
Top 10 Hldgs %
26.36%
Holding
2,855
New
45
Increased
464
Reduced
2,118
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$179M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$98.7M |
| 3 |
Kyndryl
KD
|
+$21.8M |
| 4 |
Mercury Systems
MRCY
|
+$20.2M |
| 5 |
Zions Bancorporation
ZION
|
+$19.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$33.8M |
| 2 |
Apple
AAPL
|
+$29.5M |
| 3 |
NVIDIA
NVDA
|
+$27.4M |
| 4 |
Microsoft
MSFT
|
+$26.2M |
| 5 |
Meta Platforms (Facebook)
META
|
+$17.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.11% |
| 2 | Financials | 14.21% |
| 3 | Healthcare | 11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Amerant Bancorp
AMTB
$1.15B
| $451K | ﹤0.01% |
21,845
-435
| -2% | -$9.64K |
|
|
BELFB
1777
Bel Fuse Inc Class B
BELFB
$4.25B
| $450K | ﹤0.01% |
6,017
-86
| -1% | -$6.87K |
|
1778
BrightView Holdings
BV
$1.08B
| $449K | ﹤0.01% |
35,004
-501
| -1% | -$7.17K |
|
1779
Xeris Biopharma Holdings
XERS
$1.55B
| $449K | ﹤0.01% |
81,769
-5,663
| -6% | -$22.9K |
|
1780
Wave Life Sciences
WVE
$1.02B
| $448K | ﹤0.01% |
55,403
-538
| -1% | -$5.88K |
|
1781
Orion
OEC
$364M
| $447K | ﹤0.01% |
34,595
-699
| -2% | -$9.88K |
|
|
PGRE
1782
DELISTED
Paramount Group
PGRE
| $447K | ﹤0.01% |
103,917
-5,255
| -5% | -$23.8K |
|
1783
Ichor Holdings
ICHR
$2.59B
| $446K | ﹤0.01% |
19,717
-382
| -2% | -$11.3K |
|
1784
XPEL
XPEL
$1.35B
| $446K | ﹤0.01% |
15,169
-316
| -2% | -$11.8K |
|
1785
Central Pacific Financial
CPF
$1B
| $444K | ﹤0.01% |
16,431
-245
| -1% | -$6.91K |
|
|
RC
1786
Ready Capital
RC
$289M
| $441K | ﹤0.01% |
86,717
-7,015
| -7% | -$43.2K |
|
1787
Embecta
EMBC
$290M
| $440K | ﹤0.01% |
34,545
-617
| -2% | -$9.88K |
|
1788
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $440K | ﹤0.01% |
+8,404
| New | +$437K |
|
1789
Liberty Latin America Class C
LILAK
$1.67B
| $438K | ﹤0.01% |
77,641
-2,432
| -3% | -$14.8K |
|
|
AVDL
1790
DELISTED
Avadel Pharmaceuticals
AVDL
| $438K | ﹤0.01% |
55,961
-1,107
| -2% | -$9.27K |
|
1791
Core Laboratories
CLB
$571M
| $437K | ﹤0.01% |
29,141
-453
| -2% | -$7.58K |
|
1792
PC Connection
CNXN
$2.03B
| $436K | ﹤0.01% |
6,989
-93
| -1% | -$6.18K |
|
|
PRSU
1793
Pursuit Attractions and Hospitality Inc
PRSU
$1.27B
| $435K | ﹤0.01% |
12,302
-238
| -2% | -$9.3K |
|
1794
Procore
PCOR
$9.45B
| $434K | ﹤0.01% |
6,579
-14
| -0.2% | -$1.06K |
|
1795
Healthcare Services Group
HCSG
$1.43B
| $431K | ﹤0.01% |
42,764
-3,327
| -7% | -$36.5K |
|
|
RWT
1796
Redwood Trust
RWT
$592M
| $430K | ﹤0.01% |
70,887
-4,576
| -6% | -$29.3K |
|
1797
Under Armour Class C
UA
$2.2B
| $430K | ﹤0.01% |
72,249
-1,908
| -3% | -$13K |
|
1798
Blend Labs
BLND
$331M
| $429K | ﹤0.01% |
128,207
-9,372
| -7% | -$34.1K |
|
1799
Xencor
XNCR
$1.72B
| $429K | ﹤0.01% |
40,353
-387
| -0.9% | -$6.39K |
|
1800
NB Bancorp
NBBK
$1B
| $429K | ﹤0.01% |
23,755
-496
| -2% | -$9.22K |
|
Similar funds
BA
FAM
CAM
VARA
CHP
MIC
OAG
MetLife Investment Management's Q1 2025 Portfolio in Review
As of Q1 2025, MetLife Investment Management held 2,855 positions worth $18.5B, up 0.52% from $18.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
MetLife Investment Management deployed $1.16B of net new capital in Q1 2025, opening 45 new positions and adding to 464 existing holdings. Its largest new stake was Stevanato: 633,887 shares worth $12.9M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.8M trimmed.
- MetLife Investment Management's largest Q1 2025 buy was Stevanato: 633,887 shares worth $12.9M.
- MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $179M increase.
- MetLife Investment Management's biggest Q1 2025 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.8M.
- MetLife Investment Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $7.12M.
- MetLife Investment Management's ten largest holdings make up 26% of its $18.5B portfolio in Q1 2025.
- MetLife Investment Management opened 45 new positions and closed 74 in Q1 2025.
- MetLife Investment Management's portfolio value rose 0.52% quarter-over-quarter to $18.5B.
Based on MetLife Investment Management's 13F filing for Q1 2025, filed 14 May 2025.